Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06371040
Status:
RECRUITING
Last Update Posted:
2024-04-17
First Post:
2024-03-17
Brief Title:
Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
Sponsor:
Ting Chang MD
Organization:
Tang-Du Hospital
Organization Data
Organization:
Tang-Du Hospital
Class:
OTHER
Study ID:
V10 CART-20230619
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ting Chang MD
Lead Sponsor Class:
OTHER
Responsible Party:
Ting Chang MD
Responsible Party Title:
Associate Professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Tang-Du Hospital
Old Name:
None
Old Organization:
None